Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 22-Nov-22 6:20 PM View:  | Kucherlapati Raju S Director | Gelesis Holdings, Inc. (GLSH) | 21-Nov-22 | Purchase | 92,000 | $0.45 | $41,400.00 | 94% 98.26K to 190.26K | |
| 22-Nov-22 6:20 PM View: | Kucherlapati Raju S Director | Gelesis Holdings, Inc. (GLSH) | 18-Nov-22 | Purchase | 8,000 | $0.39 | $3,120.00 | 9% 90.26K to 98.26K | |
| 17-Jun-22 10:46 AM View: | Kucherlapati Raju S Director | Gelesis Holdings, Inc. (GLSH) | 15-Jun-22 | Purchase | 24,625 | $1.95 | $47,947.30 | 38% 65.64K to 90.26K | |
| 10-Jun-22 12:12 PM View: | Chiquette Elaine Chief Scientific Officer | Gelesis Holdings, Inc. (GLSH) | 08-Jun-22 | Grant | 80,500 | -- | -- | 44% 182.58K to 263.08K | |
| 09-May-22 4:15 PM View: | Bauerlein Alison Director | Gelesis Holdings, Inc. (GLSH) | 06-May-22 | Grant | 51,095 | -- | -- | 100% 0 to 51.09K | |
| 09-May-22 4:16 PM View: | Abraham David General Counsel | Gelesis Holdings, Inc. (GLSH) | 06-May-22 | Grant | 256,437 | -- | -- | 100% 0 to 256.44K | |
| 09-May-22 4:17 PM View: | Leider Harry L. Chief Medical Officer | Gelesis Holdings, Inc. (GLSH) | 06-May-22 | Grant | 314,090 | -- | -- | 100% 0 to 314.09K | |
| 09-May-22 4:18 PM View: | Pass David A. Chief Operating Officer | Gelesis Holdings, Inc. (GLSH) | 06-May-22 | Grant | 483,219 | -- | -- | 100% 0 to 483.22K | |
| 09-May-22 4:18 PM View: | Perks Dominic Director | Gelesis Holdings, Inc. (GLSH) | 06-May-22 | Grant | 49,270 | -- | -- | 100% 0 to 49.27K | |
| 09-May-22 4:15 PM View: | Cavanaugh Kathryn Director | Gelesis Holdings, Inc. (GLSH) | 06-May-22 | Grant | 48,814 | -- | -- | 381% 12.82K to 61.64K | |
| 09-May-22 4:16 PM View: | Christopher Clayton Director | Gelesis Holdings, Inc. (GLSH) | 06-May-22 | Grant | 49,270 | -- | -- | 11% 461.5K to 510.77K | |
| 09-May-22 4:18 PM View: | Maltz Elliot Chief Financial Officer | Gelesis Holdings, Inc. (GLSH) | 06-May-22 | Grant | 431,975 | -- | -- | 100% 0 to 431.98K | |
| 09-May-22 4:18 PM View: | Sannino Alessandro Lead Project Scientist | Gelesis Holdings, Inc. (GLSH) | 06-May-22 | Grant | 68,966 | -- | -- | 9% 761.9K to 830.87K | |
| 09-May-22 4:19 PM View: | Wildman Jane Director | Gelesis Holdings, Inc. (GLSH) | 06-May-22 | Grant | 50,182 | -- | -- | 100% 0 to 50.18K | |
| 09-May-22 4:16 PM View: | Chiquette Elaine Chief Scientific Officer | Gelesis Holdings, Inc. (GLSH) | 06-May-22 | Grant | 182,579 | -- | -- | 100% 0 to 182.58K | |
| 09-May-22 4:17 PM View: | Kucherlapati Raju S Director | Gelesis Holdings, Inc. (GLSH) | 06-May-22 | Grant | 50,639 | -- | -- | 338% 15.0K to 65.64K | |
| 09-May-22 4:17 PM View: | Fonteyne Paul R. Director | Gelesis Holdings, Inc. (GLSH) | 06-May-22 | Grant | 53,832 | -- | -- | 100% 0 to 53.83K | |
| 09-May-22 4:19 PM View: | Zohar Yishai President & CEO Director | Gelesis Holdings, Inc. (GLSH) | 06-May-22 | Grant | 960,893 | -- | -- | 113% 853.93K to 1.81M | |
| 19-Jan-22 5:05 PM View: | Kucherlapati Raju S Director | Gelesis Holdings, Inc. (GLSH) | 14-Jan-22 | Purchase | 15,000 | $6.67 | $100,050.00 | 100% 0 to 15.0K | |
| 18-Jan-22 5:00 PM View: | Cavanaugh Kathryn Director | Gelesis Holdings, Inc. (GLSH) | 13-Jan-22 | Disposition (other) | 12,825 | -- | -- | (50%) 25.65K to 12.82K | |
| 18-Jan-22 5:00 PM View: | Cavanaugh Kathryn Director | Gelesis Holdings, Inc. (GLSH) | 13-Jan-22 | Option Exercise | 12,825 | -- | -- | 100% 12.82K to 25.65K | |
| 18-Jan-22 5:00 PM View: | Cavanaugh Kathryn Director | Gelesis Holdings, Inc. (GLSH) | 13-Jan-22 | Acquisition (other) | 12,825 | -- | -- | 100% 0 to 12.82K | |
| 08-Jul-20 4:28 PM View: | Ghiselli John Director | Gelesis Holdings, Inc. (GLSH) | 06-Jul-20 | Purchase | 971 | -- | -- | 100% 0 to 0.97K |
